[go: up one dir, main page]

NO20033809D0 - Metronomisk dosering av taxaner - Google Patents

Metronomisk dosering av taxaner

Info

Publication number
NO20033809D0
NO20033809D0 NO20033809A NO20033809A NO20033809D0 NO 20033809 D0 NO20033809 D0 NO 20033809D0 NO 20033809 A NO20033809 A NO 20033809A NO 20033809 A NO20033809 A NO 20033809A NO 20033809 D0 NO20033809 D0 NO 20033809D0
Authority
NO
Norway
Prior art keywords
taxanes
metronomic dosage
metronomic
dosage
Prior art date
Application number
NO20033809A
Other languages
English (en)
Other versions
NO20033809L (no
Inventor
Joseph Fargnoli
William C Rose
Pamela Trail
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20033809D0 publication Critical patent/NO20033809D0/no
Publication of NO20033809L publication Critical patent/NO20033809L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Carpets (AREA)
  • Epoxy Compounds (AREA)
NO20033809A 2001-02-28 2003-08-27 Metronomisk dosering av taxaner NO20033809L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28
PCT/US2002/005971 WO2002067928A2 (en) 2001-02-28 2002-02-26 Metronomic dosing of taxanes for inhibiting tumor growth

Publications (2)

Publication Number Publication Date
NO20033809D0 true NO20033809D0 (no) 2003-08-27
NO20033809L NO20033809L (no) 2003-10-23

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033809A NO20033809L (no) 2001-02-28 2003-08-27 Metronomisk dosering av taxaner

Country Status (31)

Country Link
EP (1) EP1372636B1 (no)
JP (1) JP2004538253A (no)
KR (1) KR20030086276A (no)
CN (1) CN1533273A (no)
AR (1) AR033609A1 (no)
AT (1) ATE331511T1 (no)
BG (1) BG108167A (no)
BR (1) BR0207519A (no)
CA (1) CA2439299A1 (no)
CY (1) CY1105468T1 (no)
CZ (1) CZ20032232A3 (no)
DE (2) DE60212813T2 (no)
DK (1) DK1372636T3 (no)
EE (1) EE200300413A (no)
ES (1) ES2211374T3 (no)
HR (1) HRP20030775A2 (no)
HU (1) HUP0402115A2 (no)
IL (1) IL157356A0 (no)
IS (1) IS6924A (no)
MX (1) MXPA03007655A (no)
NO (1) NO20033809L (no)
PE (1) PE20020955A1 (no)
PL (1) PL373376A1 (no)
PT (1) PT1372636E (no)
RU (1) RU2003129233A (no)
SK (1) SK10332003A3 (no)
TR (1) TR200400375T3 (no)
UY (1) UY27185A1 (no)
WO (1) WO2002067928A2 (no)
YU (1) YU66603A (no)
ZA (1) ZA200306450B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
EP1673069B1 (en) * 2003-10-15 2016-10-12 SynCore Biotechnology CO., LTD Cationic liposomes comprising an active drug for use in treatment of cancer
US9233094B2 (en) 2005-05-04 2016-01-12 Medigene Ag Method of administering a cationic liposomal preparation
US8168216B2 (en) 2006-03-22 2012-05-01 Medigene Ag Treatment of triple receptor negative breast cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0003546A3 (en) * 1997-05-27 2002-12-28 Baker Norton Pharma Compositions for administering taxanes orally to human patients
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
SK10332003A3 (sk) 2005-03-04
HUP0402115A2 (hu) 2005-02-28
IL157356A0 (en) 2004-02-19
DK1372636T3 (da) 2006-11-06
ES2211374T1 (es) 2004-07-16
HRP20030775A2 (en) 2005-02-28
BG108167A (en) 2004-09-30
AR033609A1 (es) 2003-12-26
DE60212813T2 (de) 2007-01-18
EP1372636A2 (en) 2004-01-02
KR20030086276A (ko) 2003-11-07
RU2003129233A (ru) 2005-02-10
MXPA03007655A (es) 2003-12-04
CN1533273A (zh) 2004-09-29
UY27185A1 (es) 2002-09-30
CZ20032232A3 (en) 2004-06-16
PL373376A1 (en) 2005-08-22
BR0207519A (pt) 2005-03-08
NO20033809L (no) 2003-10-23
ZA200306450B (en) 2004-11-19
IS6924A (is) 2003-08-22
DE60212813D1 (de) 2006-08-10
DE02723255T1 (de) 2004-07-15
PE20020955A1 (es) 2002-10-30
EE200300413A (et) 2003-12-15
WO2002067928A3 (en) 2003-10-09
WO2002067928A2 (en) 2002-09-06
EP1372636B1 (en) 2006-06-28
CA2439299A1 (en) 2002-09-06
TR200400375T3 (tr) 2004-04-21
PT1372636E (pt) 2006-09-29
CY1105468T1 (el) 2010-04-28
ATE331511T1 (de) 2006-07-15
YU66603A (sh) 2006-08-17
ES2211374T3 (es) 2007-03-01
JP2004538253A (ja) 2004-12-24

Similar Documents

Publication Publication Date Title
ATE296619T1 (de) Feste orale dosierungsform von simethicon
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
DK1420759T3 (da) Farmaceutiske sammensætninger til behandling af astma
NO20034127D0 (no) Forbedring av aromainneholdende bestanddeler
PL370109A1 (pl) Sposoby rozsyłania grupowego treści
NO20040053L (no) Syntese av taxol forsterkende midler
NO20052348D0 (no) Behandling av hemoragisk sjokk
NO20044916L (no) Preparater av sulfinylacetamid
FI20010558A0 (fi) Kappaleiden paikannus
NO20033737L (no) PEG-konjugater av HGT-NK4
NO20042667L (no) Fremgangsmate for fremstilling av escitalopram
NO20041968L (no) Anvendelse av cystationin
EP1438664A4 (en) Subnet pooling
PT1429628E (pt) Mistura de micronutrientes contendo bases
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
NO20035146L (no) Granulaere preparater av gaboksadol
NO20033809L (no) Metronomisk dosering av taxaner
NO20043948L (no) Fremstilling av olefiner
SE0302361L (sv) Inhibering av upptagning av monoamin
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
NO20033073L (no) Farmasöytisk sammensetning inneholdende citalopram
NO20033163D0 (no) Ny anvendelse av iloperidon
SE0501015L (sv) Befuktning av liten mängdvara
FI20010892A0 (fi) Menetelmä ksylitolin valmistamiseksi